Skip to main content

The Big Fish, Part II: Privately Held Texas-Based Biomedical Companies with Annual Revenues Exceeding $10 Million

In my previous post I had assembled a list of Texas-based LifeSci/MedTech companies listed on the two major US stock exchanges, NYSE and NASDAQ [Note: I've added an additional company, Hanger, Inc., to the list since originally publishing the post]. I felt this was a good start, but I realized I'd also have to identify the large privately held companies in order to get a really good sense of who the major players are in the Texas biomedical industry.

I decided to define "largeness" as a function of the company's latest annual revenue as reported by LexisNexis*. I used a cut-off of $10 million, which seemed reasonable with respect to the annual revenues being reported by the NYSE- and NASDAQ-listed companies seen previously. I excluded companies that are subsidiaries of other LifeSci/MedTech companies. I did, however, include companies that are owned by private equity.  

Below is the list of privately held TX-based biomedical companies with annual revenues exceeding $10 million:


(Open spreadsheet as a separate page here.)

KCI, a San Antonio-based medical device company specializing in wound care, really stands out from the pack with its annual revenue exceeding its closest competitor's by more than 15-fold**. Overall, I was excited to find a diverse mix of companies working in very different areas: molecular diagnostics, nutritional supplements, Pharma CRO, medical devices, etc. I have to admit, though, that I was somewhat disappointed by the absence from the list of pharma/biotech companies working on developing and selling therapeutic small molecules/biologicals.  


-Isamu Hartman, PhD

(Next post - back to the SBIR database!)


---------------------------------------
* technical note:  In my LexisNexis search I used NAICS codes 32541, 54171, 541512, 334510, 339112, and 339113, and SIC codes 2833, 2834, 2835, 2836, 3821, 3841, 3842, and 8731. 

** KCI, initially a NYSE-listed company, briefly went private from 1997 to 2004 and then became private again when acquired by its current owner, Apax Partners LLP, in 2011 (see http://en.wikipedia.org/wiki/Kinetic_Concepts_Inchttp://www.apax.com/).

Comments

Popular posts from this blog

Comics About Patents (A Work In Progress)

Back in January and February of 2018, I spent some time creating two four-panel comics about the process of 1) obtaining patent protection, and 2) monetizing those patent rights by licensing them. I drew the comics to serve as an illustration of concepts that I often find myself explaining to others in the course of my work. I've already shared these comics through  Twitter  and  Facebook  (click on either of link to see more of the creative process!). However, I thought I'd share them with my blog's readership as well. Please enjoy! I'm really hoping to reignite this project at some point in the future and create more episodes. (Click on the images below to enlarge) Episode 1: Episode 2: - Isamu Hartman

The Big Fish: Texas-Based Biomedical Companies listed on NYSE and NASDAQ

[Monday, 22 April 2013:  I added Hanger Inc. (HGR, NYSE), an Austin-based prosthetics and orthotics company I had originally missed, to the list] [Thursday, 02 May 2013:  fixed the location of Hanger Inc. (HGR, NYSE) - changed from Dallas to Austin] I have another few posts coming up on Texas-based awardees of the SBIR program. But first, a quick digression. +Levi Shapiro  asked me the following question during a phone conversation we had earlier today:  who are the "Big Players" in the Texas biomedical industry that are listed in the major stock exchanges? I knew about Luminex (LMNX, NASDAQ) off the top of my head. Other than that, though, I really had no idea. Following the advice of +Lauren Nise  , I used LexisNexis (courtesy of the UT Dallas Eugene McDermott Library ) to generate a list of publicly traded biomedical companies headquartered in Texas that are listed in either NYSE or NASDAQ. Here are the companies I found: (Open spreadsheet as a se...

Developing Software: What Should Academic Researchers Keep in Mind? (Part 1)

Having never had any experience in software development when I entered the world of academic technology transfer back in 2013, I never expected to learn so much in the intervening years about software licensing and commercialization. It turns out that, even working in technology transfer at a medical institution, I encounter a surprising number of software-based technologies. Furthermore, with the recent rise in the use of AI/ML applications in biomedical research, the frequency at which I am presented with software in my work is only increasing.  Below is my first attempt at summarizing what I have learned thus far in managing software assets within an academic technology transfer setting. None of what I write here should be viewed as constituting legal advice. Furthermore, if you are an academic researcher, you should most definitely rely on the guidance you receive from your own institution’s own technology transfer office when navigating these waters! However, I’m sharing my ob...